Investors
Financials
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 15, 2026 – Q1 2026 Sales
April 22, 2026 – 2025 Annual Results
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 9, 2026 – 2025 Annual Results
April 16, 2026 – Q1 2026 Sales
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Transcript of Mauna Kea Technologies full year 2019 financial results and first quarter 2020 sales results conference call
Mauna Kea Technologies reports full year 2019 financial results and first quarter 2020 sales results
Mauna Kea Technologies secures approval to access €6M second tranche of loan agreement with the European Investment Bank (EIB)
Fourth quarter and full year 2019 sales
2020 Financial Calendar
Mauna Kea Technologies Announces Strategic Equity Investment of €7.5 Million by Johnson & Johnson Innovation
Third Quarter Sales and First Nine Months of 2019 Sales
Transcript of Mauna Kea Technologies H1 2019 Financial Results Conference Call
First Half 2019 Financial Results
Mauna Kea Technologies Reports Second Quarter and First Half 2019 Sales
MAUNA KEA TECHNOLOGIES REPORTS FIRST QUARTER 2019 SALES
Transcript of Mauna Kea Technologies 2018 Financial Results Conference Call
No results found.
News
Mauna Kea Technologies and TaeWoong Medical USA Announce Exclusive Partnership to Accelerate Commercial Expansion in the U.S. in Pancreatic Cyst Management
Mauna Kea Technologies Receives NMPA Regulatory Approval in China for its Next-Generation Cellvizio® Platform
Mauna Kea Technologies Announces the Successful Completion of Its Financial Restructuring and €6M Capital Raise
No results found.